{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:58:51Z","timestamp":1740146331081,"version":"3.37.3"},"reference-count":14,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0190579","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T18:32:34Z","timestamp":1516905154000},"page":"e0190579","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U\/mL (Gla-300) versus insulin glargine 100 U\/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7833-9050","authenticated-orcid":true,"given":"Jean-Fran\u00e7ois","family":"Yale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy Hodson","family":"Pettus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Brito-Sanfiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Lavalle-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Merino-Trigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Stella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soazig","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Buzzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"issue":"Suppl. 1","key":"ref1","first-page":"S1","article-title":"Standards of medical care in diabetes\u2013 2016","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"SE Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2337\/dc14-0006","article-title":"New insulin glargine 300 Units.mL<sup>-1<\/sup> provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units.mL<sup>-1<\/sup>","volume":"38","author":"RH Becker","year":"2015","journal-title":"Diabetes Care"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/dom.12438","article-title":"New insulin glargine 300 U\/ml compared with glargine 100 U\/ml in insulin-naive people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)","volume":"17","author":"GB Bolli","year":"2015","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2337\/dc14-0990","article-title":"New insulin glargine 300 units\/mL versus glargine 100 units\/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2)","volume":"37","author":"H Yki-Jarvinen","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.diabet.2012.08.003","article-title":"Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: the HYPOCRAS study","volume":"38","author":"A Penfornis","year":"2012","journal-title":"Diabetes Metab"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s00125-007-0633-0","article-title":"Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes","volume":"50","author":"V Fonseca","year":"2007","journal-title":"Diabetologia"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/dme.12561","article-title":"Efficacy and safety of dipeptidyl peptidase-4 inhibitors as an add-on to insulin treatment in patients with Type 2 diabetes: a review","volume":"31","author":"CS Frandsen","year":"2014","journal-title":"Diabet Med"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13300-015-0105-3","article-title":"A randomized clinical trial to evaluate the efficacy and safety of co-administration of sitagliptin with intensively titrated insulin glargine","volume":"6","author":"C Mathieu","year":"2015","journal-title":"Diabetes Ther"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"992","DOI":"10.2174\/15701611113119990103","article-title":"Combination therapies of DPP4 inhibitors and GLP1 analogues with insulin in type 2 diabetic patients: a systematic review","volume":"11","author":"EC Rizos","year":"2013","journal-title":"Curr Vasc Pharmacol"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1463-1326.2009.01124.x","article-title":"Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA<sub>1c<\/sub> without causing weight gain or increased hypoglycaemia","volume":"11","author":"J Rosenstock","year":"2009","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1463-1326.2009.01173.x","article-title":"Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes","volume":"12","author":"T Vilsboll","year":"2010","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.2337\/dc12-2718","article-title":"Effects of adding linagliptin to basal insulin regimen for inadequately controlled type 2 diabetes: a \u226552-week randomized, double-blind study","volume":"36","author":"H Yki-Jarvinen","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2337\/diacare.28.5.1245","article-title":"Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia","volume":"28","year":"2005","journal-title":"Diabetes Care"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0190579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T06:03:37Z","timestamp":1660370617000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0190579"}},"subtitle":[],"editor":[{"given":"No\u00ebl C.","family":"Barengo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0190579","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,1,25]]}}}